MEEDER ASSET MANAGEMENT INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$23,000
+15.0%
692
+19.3%
0.00%0.0%
Q2 2022$20,000
+42.9%
580
+87.7%
0.00%0.0%
Q1 2022$14,000
-94.0%
309
-91.8%
0.00%
-91.7%
Q3 2021$235,000
-47.1%
3,760
-29.9%
0.01%
-42.9%
Q2 2021$444,000
+59.7%
5,366
+27.9%
0.02%
+50.0%
Q1 2021$278,000
+6850.0%
4,194
+9017.4%
0.01%
+1300.0%
Q4 2020$4,000
-97.1%
46
-98.6%
0.00%
-88.9%
Q3 2020$140,000
+15.7%
3,242
+15.1%
0.01%
+12.5%
Q2 2020$121,000
+152.1%
2,816
+61.4%
0.01%
+100.0%
Q1 2020$48,000
-74.7%
1,745
-41.9%
0.00%
-66.7%
Q4 2019$190,000
+21.0%
3,001
-46.6%
0.01%
+20.0%
Q3 2019$157,000
-31.1%
5,620
-34.9%
0.01%
-37.5%
Q2 2019$228,000
+142.6%
8,631
+69.4%
0.02%
+128.6%
Q1 2019$94,000
+8.0%
5,095
-26.2%
0.01%
-12.5%
Q4 2018$87,000
-32.6%
6,908
+1.9%
0.01%
-20.0%
Q3 2018$129,000
+2050.0%
6,776
+414.1%
0.01%
+900.0%
Q3 2017$6,000
+200.0%
1,318
-2.0%
0.00%
Q2 2017$2,0000.0%1,3450.0%0.00%
Q1 2017$2,000
-33.3%
1,345
-33.3%
0.00%
Q4 2016$3,0002,0150.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,328$51,213,00030.37%
JOHNSON & JOHNSON 3,260,869$203,576,00017.86%
ACT CAPITAL MANAGEMENT, LLC 194,000$12,111,0006.28%
Aquilo Capital Management, LLC 527,926$32,958,0005.99%
Evolutionary Tree Capital Management, LLC 105,491$6,586,0002.92%
ACUTA CAPITAL PARTNERS, LLC 121,500$7,585,0002.68%
L1 Capital Pty Ltd 297,915$18,599,0002.31%
Avidity Partners Management LP 673,700$42,059,0000.93%
Hood River Capital Management LLC 338,734$21,147,0000.65%
Tygh Capital Management, Inc. 64,127$4,003,0000.54%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders